Results for tag: "Prostatic Hyperplasia Drug"

Prostatic Hyperplasia (BPH) is a condition in which the prostate gland enlarges, causing urinary symptoms such as difficulty urinating, frequent urination, and a weak urine stream. Prostate cancer drugs are used to treat BPH, as well as to reduce the risk of prostate cancer. These drugs work by blocking the action of testosterone, which can cause the prostate to enlarge. Commonly used drugs include alpha-blockers, 5-alpha reductase inhibitors, and anti-androgens. Alpha-blockers relax the muscles of the bladder neck and prostate, allowing for easier urination. 5-alpha reductase inhibitors reduce the production of dihydrotestosterone, which can cause prostate enlargement. Anti-androgens block the action of testosterone on the prostate. Companies in the Prostatic Hyperplasia Drug market include Astellas Pharma, Merck, Pfizer, GlaxoSmithKline, and Sanofi. Show Less Read more